Phosphorylated and ubiquitinated TAR DNA binding protein 43 (TDP-43) pathology is the neurodegenerative hallmark of the vast majority of amyotrophic lateral sclerosis (ALS) and approximately half of all frontotemporal lobar degeneration (FTLD) cases. An RNA/DNA-binding protein with diverse roles in the nucleus, TDP-43 accumulates in the cytoplasm of affected neurons and glia in disease, indicating that both a loss of normal nuclear function and additional gain of toxicity due to increased cytoplasmic presence likely occur in these TDP-43 proteinopathies. Abundance and splicing of hundreds of transcripts are affected by dysfunction of TDP-43, making identification of the key pathways involved in disease pathogenesis a difficult task. However...
Received: 2015.05.10; Accepted: 2015.06.18; Published: 2015.07.21 TAR DNA binding protein 43 (TDP-43...
TAR DNA-binding protein 43 (TDP-43) proteinopathy is a key pathological feature of a majority of amy...
# The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Therap...
Nuclear depletion, abnormal modification, and cytoplasmic aggregation of TAR DNA-binding protein 43 ...
<div><p>In amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, TAR DNA bindin...
In amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, TAR DNA binding protei...
TAR DNA-binding protein 43 (TDP-43) forms abnormal ubiquitinated and phosphorylated inclusions in br...
Mutations in fused-in-sarcoma (FUS) and TAR DNA binding protein-43 (TDP-43; TARDBP) are known to cau...
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the ...
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the ...
Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of upper and lower motor ne...
TAR DNA binding protein 43 (TDP-43) is a versatile RNA/DNA binding protein involved in RNA-related m...
Aggregation of misfolded TAR DNA-binding protein 43 (TDP-43) is a striking hallmark of neurodegenera...
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disorder characterized by muscle weaknes...
International audienceTransactivation response DNA binding protein 43 kDa (TDP-43) is known to be a ...
Received: 2015.05.10; Accepted: 2015.06.18; Published: 2015.07.21 TAR DNA binding protein 43 (TDP-43...
TAR DNA-binding protein 43 (TDP-43) proteinopathy is a key pathological feature of a majority of amy...
# The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Therap...
Nuclear depletion, abnormal modification, and cytoplasmic aggregation of TAR DNA-binding protein 43 ...
<div><p>In amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, TAR DNA bindin...
In amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, TAR DNA binding protei...
TAR DNA-binding protein 43 (TDP-43) forms abnormal ubiquitinated and phosphorylated inclusions in br...
Mutations in fused-in-sarcoma (FUS) and TAR DNA binding protein-43 (TDP-43; TARDBP) are known to cau...
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the ...
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the ...
Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of upper and lower motor ne...
TAR DNA binding protein 43 (TDP-43) is a versatile RNA/DNA binding protein involved in RNA-related m...
Aggregation of misfolded TAR DNA-binding protein 43 (TDP-43) is a striking hallmark of neurodegenera...
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disorder characterized by muscle weaknes...
International audienceTransactivation response DNA binding protein 43 kDa (TDP-43) is known to be a ...
Received: 2015.05.10; Accepted: 2015.06.18; Published: 2015.07.21 TAR DNA binding protein 43 (TDP-43...
TAR DNA-binding protein 43 (TDP-43) proteinopathy is a key pathological feature of a majority of amy...
# The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Therap...